Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

OptimizeRx Corporation (OPRX)

13.78   -0.12 (-0.86%) 03-21 16:00
Open: 13.91 Pre. Close: 13.9
High: 14.31 Low: 13.7001
Volume: 36,847 Market Cap: 167M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.331 - 14.432 14.432 - 14.508
Low: 13.443 - 13.576 13.576 - 13.678
Close: 13.596 - 13.776 13.776 - 13.914

Technical analysis

as of: 2019-03-21 4:30:16 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 18.35     One year: 21.43
Support: Support1: 13.31    Support2: 11.82
Resistance: Resistance1: 15.71    Resistance2: 18.35
Pivot: 14.64
Moving Average: MA(5): 14.45     MA(20): 14.42
MA(100): 13.54     MA(250): 10.99
MACD: MACD(12,26): 0.37     Signal(9): 0.54
Stochastic oscillator: %K(14,3): 30.94     %D(3): 46.99
RSI: RSI(14): 47.15
52-week: High: 18.39  Low: 1.40  Change(%): 824.8
Average Vol(K): 3-Month: 6328  10-Days: 4191

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OPRX has closed above bottom band by 4.9%. Bollinger Bands are 52.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPRX's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 14 Mar 2019 09:07:26 Z
Validea Motley Fool Strategy Daily Upgrade Report - 3/14/2019

Tue, 18 Dec 2018 20:07:00 Z
Mid-Day Market Update: Crude Oil Down Over 3%; Biocept Shares Spike Higher

Tue, 11 Dec 2018 21:37:10 Z
Health Care Sector Update for 12/11/2018: OPRX,ITCI,ENTX,AMGN,RARX

Mon, 29 Oct 2018 15:12:01 Z
OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For

Mon, 08 Oct 2018 16:14:36 Z
Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Technology
Industry:  Health Information Services
Shares Out. (M) 12.10
Shares Float (M) 11.96
% Held by Insiders 1.20
% Held by Institutions 35.10
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Book Value (p.s.) 9.830
PEG Ratio 3.00
Profit Margin 1.07
Operating Margin 0.85
Return on Assets (ttm) 1.3
Return on Equity (ttm) 1.8
Qtrly Rev. Growth 64.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E
P/E Growth Ratio
P/BV 1.40
P/S 84648568.00
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-05-14
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.